Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01802203 · ClinicalTrials.gov registry record
trūFreeze® Spray Cryotherapy Patient Registry
A clinical trial of Barrett Esophagus and Esophageal Neoplasm, sponsored by US Endoscopy Group.
- Completed
- Registry status
- 275
- Enrollment target
- 16
- Study locations
NCT01802203: Completed study of Barrett Esophagus and Esophageal Neoplasm, sponsored by US Endoscopy Group.
NCT01802203 is a study of Barrett Esophagus and Esophageal Neoplasm that has completed, run by US Endoscopy Group. The registered enrollment target is 275 participants, below the 3,557-participant average among 32 other Barrett Esophagus trials with a reported enrollment target (92% lower). The trial reports 16 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01802203, a study of Barrett Esophagus and Esophageal Neoplasm, has completed, sponsored by US Endoscopy Group.
- COMPLETED
- Registry status
- 275 participants
- Enrollment target
- 16
- Study locations
Study Summary
To collect efficacy and outcomes data related to the use of trūFreeze® spray cryotherapy for the treatment of unwanted tissue in the pulmonary and gastrointestinal settings.
Primary Outcome
The registry population consists of patients who are being treated using the trūFreeze® spray cryotherapy device for the removal of unwanted tissue, such as malignant or pre-malignant conditions in the pulmonary or gastrointestinal settings.
Conditions Studied
Interventions
- DEVICE truFreeze Spray Cryotherapy
Study Locations (16)
Massachusetts
- Massachusetts General Hosptial - Boston
- Boston University Medical Center - Boston
- Beth Israel Deaconess Medical Center - Boston
New York
- ProHEALTH Care Associates - Lake Success
- NYU - New York
- University of Rochester/Strong Memorial Medical Center - Rochester
Maryland
- University of Maryland - Baltimore
- Walter Reed National Military Medical Center - Bethesda
California
- Scripps Green Hosptial - La Jolla
Colorado
- University of Colorado Denver - Denver
Florida
- Borland-Groover Clinic - Jacksonville
Louisiana
- Ochsner Medical Center - Kenner
North Carolina
- University of North Carolina at Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 275 participants |
| Start Date | 2013-04 |
| Est. Completion | 2022-04 |
What the finished NCT01802203 record still lists
NCT01802203 is an observational study that tracks outcomes without assigning an intervention. The registered 275 participants enrollment target is mid-sized for trials with a published cap, below the 3,557-participant average among 32 other Barrett Esophagus trials with a reported enrollment target (92% lower).
The record links to 6 conditions, with Barrett Esophagus appearing as the primary indexed condition, and to 1 intervention - of which truFreeze Spray Cryotherapy is the first listed.
NCT01802203 lists 16 locations in 11 states (Massachusetts, New York, Maryland).
Frequently Asked Questions
What is clinical trial NCT01802203 about?
NCT01802203 is a clinical study titled "trūFreeze® Spray Cryotherapy Patient Registry". To collect efficacy and outcomes data related to the use of trūFreeze® spray cryotherapy for the treatment of unwanted tissue in the pulmonary and gastrointestinal settings.
What is the current status of trial NCT01802203?
This trial is currently completed. The enrollment target is 275 participants. The study started on 2013-04. Estimated completion is 2022-04.
What conditions does trial NCT01802203 study?
This clinical trial studies the following conditions: Barrett Esophagus, Esophageal Neoplasm, Esophageal Dysplasia, Esophageal Stenosis, Bronchial Neoplasm.
What interventions are being tested in trial NCT01802203?
The interventions under investigation include: truFreeze Spray Cryotherapy (DEVICE).
Who is sponsoring clinical trial NCT01802203?
This trial is sponsored by US Endoscopy Group, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01802203 being conducted?
This trial has 16 study locations across California, Colorado, Florida, Louisiana, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Barrett Esophagus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01802203's enrollment target sits among peer trials
275 16th of 32 higher than 16 of 32 other Barrett Esophagus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Barrett Esophagus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
RECRUITING · NA
-
Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux
RECRUITING · NA
-
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
RECRUITING
-
Longitudinal Oral Microbiome Sampling for BE
RECRUITING
-
Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples
RECRUITING · NA
-
Non-Endoscopic Detection of Barrett's Esophagus Using Methylation Biomarkers on EndoSign® Cell Collection Device Samples
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269190 · 275 participants · NA
Wide-Field and High Resolution In Vivo Imaging in Visualizing Lesions in Patients With Oral Neoplasia Undergoing Surgery
- NCT01900132 · 275 participants · NA
Electrical Impedance Myography: Natural History Studies inNeuromuscular Disorders and Healthy Volunteers
- NCT04104776 · 275 participants · Phase 1
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- NCT04765150 · 275 participants
Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia